American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML
    Journal Article

    Heikamp, E. B.; Henrich, J. A.; Perner, F.; Wong, E. M.; Hatton, C.; Wen, Y.; Barwe, S. P.; Gopalakrishnapillai, A.; Xu, H.; Uckelmann, H. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
    Journal Article

    Fabrizio, V. A.; Boelens, J. J.; Mauguen, A.; Baggott, C.; Prabhu, S.; Egeler, E.; Mavroukakis, S.; Pacenta, H.; Phillips, C. L.; Rossoff, J.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Alloreactive T cells deficient of the short-chain fatty acid receptor GPR(109)A induce less graft-versus-host disease
    Journal Article

    Docampo, M. D.; da Silva, M. B.; Lazrak, A.; Nichols, K. B.; Lieberman, S. R.; Slingerland, A. E.; Armijo, G. K.; Shono, Y.; Nguyen, C.; Monette, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Chemotherapy-free regimens in frontline follicular lymphoma
    Editorial

    Batlevi, C. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Guiding the global evolution of cytogenetic testing for hematologic malignancies
    Guidelines

    Akkari, Y. M. N.; Baughn, L. B.; Dubuc, A. M.; Smith, A. C.; Mallo, M.; Dal Cin, P.; Diez Campelo, M.; Gallego, M. S.; Granada Font, I.; Haase, D. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
    Journal Article

    Clough, C. A.; Pangallo, J.; Sarchi, M.; Ilagan, J. O.; North, K.; Bergantinos, R.; Stolla, M. C.; Naru, J.; Nugent, P.; Kim, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
    Journal Article

    Chung, D. J.; Sharma, S.; Rangesa, M.; DeWolf, S.; Elhanati, Y.; Perica, K.; Young, J. W.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
    Journal Article

    Wudhikarn, K.; King, A. C.; Geyer, M. B.; Roshal, M.; Bernal, Y.; Gyurkocza, B.; Perales, M. A.; Park, J. H.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
    Journal Article

    Chiesa, R.; Boelens, J. J.; Duncan, C. N.; Kühl, J. S.; Sevin, C.; Kapoor, N.; Prasad, V. K.; Lindemans, C. A.; Jones, S. A.; Amartino, H. M.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save